This inventor holds 5 USPTO granted patents. Top assignee: American Gene Technologies International Inc.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Jeff Galvin: Innovator in HIV Immunization and Immunotherapy
Introduction
Jeff Galvin is a prominent inventor based in Rockville, MD (US), known for his significant contributions to the field of immunization and immunotherapy. With a total of five patents to his name, Galvin has focused his research on innovative methods for the treatment and prevention of HIV.
Latest Patents
Among his latest patents, Galvin has developed groundbreaking techniques related to HIV pre-immunization and immunotherapy. These inventions specifically address the enrichment of HIV-specific CD4+ T cells, utilizing both in vivo and ex vivo methods to enhance the immune response against HIV.
Career Highlights
Galvin's career is marked by his dedication to advancing medical science, particularly in the realm of infectious diseases. His work has the potential to transform the landscape of HIV treatment, offering new hope for patients worldwide.
Collaborations
Throughout his career, Galvin has collaborated with notable colleagues, including Charles David Pauza and Haishan Li. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jeff Galvin's contributions to HIV immunization and immunotherapy exemplify the impact of innovative thinking in the medical field. His patents not only reflect his expertise but also hold promise for future advancements in the treatment of HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile